Nanomedical Drug Delivery for Neurodegenerative Diseases

Dr. Awesh K. Yadav has received his B.Pharm, M.Pharm, and PhD from Dr. Hari Singh Gour University Sagar (MP). He is currently working as Assistant Professor in the Department of Pharmaceutics at the National Institute of Pharmaceutical Education and Research Raebareli, India. He has more than 15 years of teaching and industrial experience in various institutes and industries. He has written dozens of quality research publications in journals of national and international repute. He has also published four books and seven book chapters. He has been awarded the best citation award for his publication in the International Journal of Pharmaceutics in 2005. Dr. Yadav’s current research interest includes targeted and controlled novel drug delivery systems for the delivery of various bioactives such as anticancer drugs, anti-Alzheimer's drugs, anti-Parkinson drugs, anti-malarial drugs, sun-screening agents, etc.Dr. Rahul Shukla is currently working as an Assistant Professor (Contract) at Department of Pharmaceutics, NIPER Raebareli, India, He has a PhD in Pharmaceutical Sciences from CSIR CDRI and J.N.U New Delhi, India, an M.Pharm from IIT BHU,Varanasi, India and B.Pharm from Jamia Hamdard, New Delhi. He has more than ten years of research and academic experience with more than 30 publications and 10 book chapters to his credit. He has filed 7 Indian Patent and 1 Copyright. Recently he has edited a book on the Role of Novel Drug Delivery Vehicles in Nanobiomedicine. His current research interests include targeted drug delivery systems, particle engineering, controlled delivery for neurodegenerative diseases, dendrimer mediated drug delivery, solubilization and bioavailability enhancements. Dr. S. J. S. Flora is the Former Director of the National Institute of Pharmaceutical Education and Research, Raebareli (NIPER-R), Uttar Pradesh, India, since 2016. Dr. Flora was head of Division of Pharmacology and Toxicology at Defense Research and Development Establishment, Gwalior, India. He earned his PhD in 1985 from CSIR-Indian Toxicology Research Center, Lucknow, and was a postdoctoral research associate at Utah State University, USA. His most highlighted contribution has been the development of a new drug for the therapy of chronic arsenic poisoning, which was approved by the Drug Controller General of India (DCGI). He has published more than 350 research papers, 75 review articles/chapters, 18 patents, and more than 16,000 citations. He has published 6 books including the prestigious Handbook of Arsenic Toxicology and the Handbook of Arsenic Toxicology and the Handbook on Biological Warfare Preparedness published by Elsevier/Academic Press (USA).

• 1. Aetiology and pathophysiology of neurodegenerative disordersRakesh K. Sahoo, Tanisha Gupta, Smilly, Vinay Kumar, Sarita Rani, and Umesh Gupta2. Targeted nanoparticles for the treatment of Alzheimer's diseaseDavood Gheidari and Mohammad Bayat3. Neurodegenerative disorders due to inhalation of various small particlesKrishna Jadhav, Raghuraj, Eupa Ray, Kalpesh Vaghasiya, and Rahul Kumar Verma4. Lipid nanocarrier-based drug delivery for the treatment of brain-related disordersSatish Shilpi, Ashish Jain, Sonal Dixit, Gaurav Saraogi, Awesh Kumar Yadav, and Sanjay K. Jain5. Nanomedical drug delivery for neurodegenerative diseaseNavjot Kaur, Vanktesh Kumar, Thatikayala Mahender, Indrani Maji, Shrusti Mahajan, Pankaj Kumar Singh, and Sanjeev Kumar Sahu6. siRNA polymer conjugates for the delivery of RNAi therapeutics for the treatment of Parkinson's diseasePriya Singh, Nidhi Mishra, Neelu Singh, Alka Sonkar, Samipta Singh, Raquibun Nisha, Priyanka Maurya, Ravi Raj Pal, and Shubhini A. Saraf7. Potential of nanoparticles as novel therapeutics against Alzheimer's DiseaseRewati Raman Ujjwal, Sandeep Kr Maharana, Mayank Handa, and S.T.V. Sai Krishna8. Recent trends of extracellular vesticles for therapeutic intervention of brain-related diseasesMayank Handa, Reddy Gayathri Aparnasai, Nikita Panicker, Sanjiv Singh, and Munindra Ruwali9. Mitochondria-targeted drug delivery systems for the effective treatment of neurodegenerative disordersVaishali Khare, Surbhi Gupta, Preeti Bisht, and Debapriya Garabadu10. Recent trends of theranostic applications of nanoparticles in neurodegenerative disordersSarjana Raikwar and Sanjay K. Jain11. Role of nanoparticles in neurotoxicityRishi Paliwal, Kunjbihari Sulakhiya, Shivani Rai Paliwal, Vijal Singh, Rameshroo Kenwat, and Debashish Paramanik12. Metal nanoparticles for neurodegenerative diseasesShagufta Haque and Chitta Ranjan Patra13. Nano-based phytodrug delivery systems for the management of neurodegenerative disordersM.S. Sudheesh and R.S. Pawar14. Nanoparticle-mediated delivery of AChE inhibitors for the treatment of Alzheimer's diseasePallav Namdeo, Jinu Mathew, and Ashish Garg15. Nanomaterial-bsed drug delivery systems as tools for targeted therapy of neurodegenerative diseasesRahul Shukla, Vaibhavi Srivastava, Aakriti Sethi, and Munindra Ruwali16. Sample preparation techniques for quantitative analysis in brain pharmacokinetics: Application to neurodegenerative diseasesPramod Kumar, Waibiangki Lyngdoh, Banwarilal, and Amit Alexander